Polyvinyl alcohol-poly(caprolactone) semi IPN scaffold with implication for cartilage tissue engineering

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 84, Issue 2, 2008, Pages 584-594

  Mohan, Neethu ^a   Nair, Prabha D ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Articular cartilage; Matrix; Porous; Scaffolds; Tissue engineering

Indexed keywords

BLENDING; CARTILAGE; FUNCTIONAL GROUPS; HYDROPHOBICITY; PEPTIDES; POLYVINYL ALCOHOLS; SCAFFOLDS; SWELLING;

ARTICULAR CARTILAGE; CONSTITUENT POLYMERS; MATRIX; POROUS STRUCTURE;

TISSUE ENGINEERING;

PEPTIDE DERIVATIVE; POLYCAPROLACTONE; POLYESTER; POLYMER; POLYVINYL ALCOHOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HYBRID; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MOUSE; NONHUMAN; POROSITY; STRENGTH; SWELLING; TISSUE ENGINEERING;

ANIMALS; CARTILAGE; CELL LINE; CHONDROCYTES; MICE; POLYESTERS; POLYVINYL ALCOHOL; SWINE; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 38349195097     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30906     Document Type: Article

References (49)

1. Buckwalter JA, Mankin HJ. Articular cartilage: Degeneration and Osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 1998;47:487-504.
2. Lewis MM, Sissons HA, Norman A, Greenspan A. Benign and malignant cartilage tumors. Instr Course Lect 1987;36:87-114.
3. Buckwalter JA, Mankin HJ. Articular cartilage repair and transplantation. Arthritis Rheum 1998;41:1331-1342.
4. Hunter W. The structure and diseases of articulating cartilages. Philos Trans R Soc London Ser B 1743;42:514-522.
5. Pajet J. Healing of injuries in various tissues. Lect Surg Pathol 1853;1:262-270.
6. Pridie KH. A method of resurfacing osteoarthritic knee joints. J Bone Joint Surg 1959;41:618-619.
7. Ficat RP, Ficat C, Gedeon PK, Touissant JF. Spongialization: A new treatment for diseased patella. Clin Orthop Relat Res 1984;182:200-205.
8. Johnson LL. Arthroscopic abrasion, arthroplasty, historical and pathological perspective: Present status. Arthroscopy 1986;2:54-69.
9. Langer R, Vacanti JP. Tissue engineering. Science 1993;260:920-926.
10. Freed LE, Marquis JC, Nohria A, Emmanuel J, Mikos AG, Langer R. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res 1993;27:11-23.
11. Sing YC, Todd CH, Chwee TL, Kam WL. Mechanical properties of single electrospun drug-encapsulated nanofibres. Nanotechnology 2006;17:3880.
12. Kuo KC, Ma XP. Ionically crosslinked alginate hydrogels as scaffolds for tissue engineering, Part 1: Structure, gelation rate and mechanical properties. Biomaterials 2001;22:511.
13. Pitt CG, Greatzl MM, Kimmel GL. Aliphatic polyester IL The degradation of PLA, PCL and their copolymers in vivo. Biomaterials 1981;2:215-220.
14. Hutmacher DW, Schantzb JT, Zein I, Ng KW, Tan KC, Teoh SH. Mechanical properties and cell culture response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res 2001;55:203-216.
15. Azevedo MC, Reis RL, Claase MB, Gijpma DW, Feijen J. Development of polycaprolactone/hydroxy apatite composite biomaterials. J Mater Sci: Mater Med 2003;14:103-107.
16. Cai Q, Bei J, Wanc S. Synthesis and degradation of a tricomponent copolymer derived from Glycolide, L-lactide, and ε-caprolactone. J Biomater Sci Polym Ed 2000;11:273-288.
17. Calvert JW, Marra KG, Cook L, Kumta PN, Dimilla PA, Weiss LE. Characterization of osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces. J Biomed Mater Res 2000;52:279-284.
18. Fromstein JD, Woodhouse AA. Elastomeric biodegradable polyurethane blends for soft tissue applications. J Biomater Sci Polym Ed 2002;13:391-406.
19. Guan J, Sacks MS, Beckman EJ, Wagner WR. Synthesis, characterization, and cytocompatibility of elastomeric biodegradable poly (ester-urethane) ureas based on poly(caprolactone) and putrescine. J Biomed Mater Res 2002;61:493-503.
20. Guan J, Sacks MS, Beckman EJ, Wagner WR. Biodegradable poly (ether ester urethane) urea elastomers based on poly (ether ester) triblock copolymers and putrescine: Synthesis, characterization and cytocompatibility. Biomaterials 2004;25:85-96.
21. Kweon H, Yoo MK, Park IK, Kim TH, Lee HC, Lee H-S, OH J-S, Akaike T, Cho CS. A novel degradable poly (caprolactone) networks for tissue engineering. Biomaterials 2003;24:801-808.
22. Malinconico M, Immirzi B, Massenti S, La Mantia FP, Mormile L, Petti L. Blends of polyvinyl alcohol and functionalized Polycaprolactone: A study on melt extrusion and postcure of films suitable for protected cultivation. J Mater Sci 2002;37:4973-4978.
23. Htay AS, Teoh SH, Hutmacher DW. Development of perforated microthin poly (caprolactone) films as matrices for membrane tissue engineering. J Biomater Sci Polym Ed 2004;15:638-700.
24. Calandrelli L, Immirzi B, Malinconico M, Luessenheide M, Passaro I, Pasqua R, Oliva A. Natural and synthetic hydroxyapatite filled PCL: Mechanical properties and biocompatibility analysis. J Bioact Compat Polym 2004;19:301-313.
25. Mendes SC, Bezemer J, Grijpma DW, Bellia G, Innocenti DF, Reis RL, Groot K, Bitterswijk CA, Bruijn JD. Evaluation of two biodegradable polymeric systems as substrates for bone tissue engineering. Tissue Eng 2003;9:91-101.
26. Gupta P, Vermani K, Garg S. Hydrogels from controlled release to pH-responsive drug delivery. Drug Discov Today 2002;7:569-579.
27. William J, Adewunmi A, Schek R, Flanagan C, Krebsbach P, Feinberg S, Hollister S, Das S. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 2005;26:4817-4827.
28. Cao T, Ho KH, Teoh SH. Scaffold design and in vitro study of osteochondral coculture in a three-dimensional porous polycaprolactone scaffold fabricated by fused deposition modeling. Tissue Eng 2003;9:103-112.
29. Williamson MR, Coombes AG. Gravity spinning of polycaprolactone fibres for applications in tissue engineering. Biomaterials 2004;25:459-465.
30. Oh SH, Kang SG, Kim ES, Cho SH, Lee JH. Fabrication and characterization of hydrophilic poly (lactic-co-glycolic)/poly (vinyl alcohol) blend cell scaffolds by melt-molding particulate-leaching method. Biomaterials 2003;24:4011-4021.
31. Burczak K, Gamian E, Kochman A. Long-term in vivo performance and biocompatibility of poly(vinyl-alcohol) hydrogel macrocapsules for hybrid-type artificial pancreas. Biomaterials 1996;17:2351-2356.
32. Li RH, White M, Williams S, Hazlett TJ. Poly(vinyl alcohol) synthetic polymer foams as scaffolds for cell encapsulation. Biomater Sci Polym Ed 1998;9:239-258.
33. Grisel Y, Saavedra L, Mateescu M, Diana A, Bates A, Devisee F. Polyvinyl alcohol three-dimensional matrices for improved long-term dynamic culture of hepatocytes. J Biomed Mater Res A 2003;66:562-570.
34. Pereira MM, Jones JR, Hench LL. Bioactive glass and hybrid scaffolds prepared by sol-gel method for bone tissue engineering. Adv Appl Ceram 2005;104:35-42.
35. ASTM 1131-03. Standard test method for compositional analysis by thermogravimetry. West Conshohocken, PA: ASTM International. 2003.
36. ASTM E 1356-03. Standard test method for assignment of the glass transition temperature by differential scanning calorimeter and differential thermal analysis. West Conshohocken, PA: ASTM International. 2003.
37. ASTM D 895-96. Standard test method for compressive properties of rigid plastics. West Conshohocken, PA: ASTM International. 1996.
38. International Standardization Organization. Biological evaluation of medical devices. Part 5. Tests for Cytotoxicity: In vitro Methods. ISO 10993-5. Geneva, Switzerland: International Organization for Standardization; 1992.
39. Rosenberg L. Chemical basis for the histological use of Safranin O in the study of articular cartilage. J Bone Joint Surg Am 1971;53:69-82.
40. Lee JH, Park JW, Lee HB. Cell adhesion and growth on polymer surfaces with hydroxyl groups prepared by water vapour plasma treatment. Biomaterials 1991;12:443-448.
41. Quirk RA, Chan WC, Davies MC, Tendler SJ, Shakesheff KM. Poly (L-lysine)-GRGDS as a biomimetic surface modifier for poly (lactic acid). Biomaterials 2001;22:865-872.
42. Yang XB, Roach HI, Clarke P, Howdle SM, Quirk R, Shakesheff KM, Oreffo ROC. Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. Bone 2001;29:523-531.
43. Klee D, Höcker H. Polymers for biomedical applications: Improvement of the interface compatibility. Adv Polym Sci 1999;149:1-57.
44. Cui YL, Hou X, Qi AD, Wang XH, Wang H, Cai KY, Yin YJ, Yao KD. Biomimetic surface modification of poly(L-lactic acid) with gelatin and its effects on articular chondrocytes in vitro. J Biomed Mater Res 2003;66:770-778.
45. Hearn MTW, Smith PK, Mallia AK, Hermanson GT. Preparative and analytical applications of CDI-mediated affinity chromatography. Horváth, Cs. ed. In: Affinity Chromatography and Biological Recognition. New York: Academic Press; 1983. pp 191-196.
46. Hearn MTW, Bethell GS, Ayers JS, Hanock WS. Application of 1, 1-carbonyldiimidazole- activated agarose for purification of proteins. J Chromatogr 1979;185:463-470.
47. Kinner B, Spector M. Smooth muscle actin expression by human articular chondrocytes and their contraction of a collagen-glycosaminoglycan matrix in vitro. J Orthop Res 2006;19:233.
48. Wu L, Ding J. Invitro degradationof three dimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 2004;25:5821.
49. Shapiro I, Cohen S. Novel alginate sponges for cell culture and transplantation. Biomaterials 1997;18:583.